[LXRX] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
12-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 92.76%
YoY- 83.16%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 33,047 23,037 127,280 21,482 1,410 218 343 113.96%
PBT -32,387 -32,419 86,750 -3,003 -17,414 -24,873 -33,845 -0.73%
Tax -4,009 37 1,612 -70 -174 -55,799 -56,267 -35.58%
NP -28,378 -32,419 86,750 -2,933 -17,414 -24,873 -33,845 -2.89%
Tax Rate - - -1.86% - - - - -
Total Cost 61,425 55,456 40,530 24,415 18,824 25,091 34,188 10.24%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -85.87 -140.73 68.16 -13.65 -1,235.04 -11,409.63 -9,867.35 -54.61%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -0.27 -0.31 0.84 -0.03 -0.24 -0.34 -0.49 -9.44%
EPS Diluted -0.27 -0.31 0.76 -0.03 -0.24 -0.34 -0.49 -9.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.